<DOC>
	<DOC>NCT02835664</DOC>
	<brief_summary>This study will investigate the effects of 6 week Nicotinamide Riboside supplementation (1000 mg/day) on metabolic health in healthy (pre)obese humans. The primary objective will be hepatic and whole body insulin sensitivity. Secondary objectives, to provide information about the underlying mechanism, will be muscle mitochondrial function, brown fat activity, ectopic lipid accumulation, energy metabolism, cardiovascular risk parameters, body composition and acetylcarnitine levels.</brief_summary>
	<brief_title>Nicotinamide Riboside and Metabolic Health</brief_title>
	<detailed_description />
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Niacinamide</mesh_term>
	<mesh_term>Niacin</mesh_term>
	<mesh_term>Nicotinic Acids</mesh_term>
	<criteria>Signed informed consent Caucasian Males and postmenopausal females Aged 4565 years at start of the study Body mass index (BMI) 27 35 kg/m2 Stable dietary habits (no weight loss or gain &gt;5kg in the past 3 months) Sedentary lifestyle (not more than 2 hours of sports per week) Type 2 diabetes Active diseases (cardiovascular, diabetes, liver, kidney, cancer or other) Contraindication for MRI Participation in earlier research or medical examination that included PET/CT scanning Alcohol consumption of &gt;2 servings per day Smoking in the past 6 months</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Nicotinamide Riboside</keyword>
	<keyword>Obesity</keyword>
	<keyword>Metabolic health</keyword>
	<keyword>Insulin resistance</keyword>
	<keyword>Mitochondrial function</keyword>
	<keyword>Brown adipose tissue</keyword>
	<keyword>Energy expenditure</keyword>
	<keyword>Ectopic lipid accumulation</keyword>
	<keyword>Cardiovascular risk</keyword>
	<keyword>Acetylcarnitine</keyword>
</DOC>